微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 8-K Current report, items 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001274737-23-000002 Act: 34 Size: 5 MB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-22-000083 Size: 5 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.05, 5.02, and 9.01 Accession Number: 0001274737-22-000080 Act: 34 Size: 249 KB 网页链接
$Exagen(XGN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-22-000623 Act: 34 Size: 30 KB 网页链接
$Exagen(XGN)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-22-000075 Act: 34 Size: 7 MB 网页链接
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-22-000076 Act: 34 Size: 7 MB 网页链接
$Exagen(XGN)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001274737-22-000071 Act: 34 Size: 45 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02, 4.02, and 9.01 Accession Number: 0001274737-22-000070 Act: 34 Size: 322 KB 网页链接
$Exagen(XGN)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001274737-22-000067 Act: 34 Size: 370 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-22-000010 Size: 5 KB 网页链接